Cargando…
New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883200/ https://www.ncbi.nlm.nih.gov/pubmed/20582170 http://dx.doi.org/10.4103/1817-1737.62468 |
_version_ | 1782182241446658048 |
---|---|
author | Koshak, Emad A. |
author_facet | Koshak, Emad A. |
author_sort | Koshak, Emad A. |
collection | PubMed |
description | |
format | Text |
id | pubmed-2883200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-28832002010-06-25 New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist Koshak, Emad A. Ann Thorac Med Editorial Medknow Publications 2010 /pmc/articles/PMC2883200/ /pubmed/20582170 http://dx.doi.org/10.4103/1817-1737.62468 Text en © Annals of Thoracic Medicine http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Koshak, Emad A. New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title | New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title_full | New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title_fullStr | New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title_full_unstemmed | New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title_short | New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist |
title_sort | new fda safety warnings for labas: a call for asthma guidelines revisit for solo beta agonist |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883200/ https://www.ncbi.nlm.nih.gov/pubmed/20582170 http://dx.doi.org/10.4103/1817-1737.62468 |
work_keys_str_mv | AT koshakemada newfdasafetywarningsforlabasacallforasthmaguidelinesrevisitforsolobetaagonist |